Allurion to Go Public on NYSE

One of SMA’s portfolio companies, Allurion Technologies, announced last week that they have reached a business combination agreement with Compute Health, through which Allurion will be going public on NYSE via a SPAC merger. Allurion is an exceptional company, run by a gold standard team of industry executives, led by co-founder Shantanu Gaur. They will now be joined by, for instance, Omar Ishrak, former CEO and Chairman of Medtronic, as Co-Chair of the merged entity. As a commercial company, Allurion has a consistent track record of success, having grown sales from launch in 2016 to $64m in 2022. The SMA team is proud to be partnered with the Allurion team in one of our first investments. Allurion’s SPAC merger is SMA’s first public “value crystallisation event”, announced just less than two years after SMA had its first funding close.